LlamaLab vs U.S. Legal Support

Plaintiff evidence in days, not weeks. The AI-native alternative to all-in-one litigation support.

What is record retrieval?
Same-day retrieval
AI provider discovery
Clinical qualification
American RetrievalLexitasU.S. Legal SupportTavrnWisedocs

Purpose-built for plaintiff evidence

LlamaLab excels as an AI-native medical-evidence platform best suited for plaintiff firms focused on case outcomes, particularly same-day retrieval with reverse provider discovery, a licensed clinical team that qualifies proof of injury, and mass tort portfolio intelligence and recoverable pricing. U.S. Legal Support fits large organizations that want all-inclusive litigation support at maximum national scale.

Capability
LlamaLab
U.S. Legal Support
Category focus
AI-native medical evidence for plaintiff firms
All-inclusive litigation support at scale
Track record
Trusted by 250+ law firms; AI-native since 2024
Nationwide since 1996
Retrieval turnaround
Same-day to 48 hours
Not publicly disclosed; expediting teams in every time zone
Provider discovery
Proprietary 4M+ facility network; reverse search finds ~3x more providers than client memory
Retrieves from named providers; 1,100,000+ provider relationships
Case qualification
Licensed clinical team qualifies proof of injury in under 7 days
Medical summaries and treatment chronologies
Portfolio / AI queries
Plain-English queries for complex medical records across the entire portfolio
Client portal for records management and invoicing
Pricing & recoverability
Retrieval-only billing, no platform fees, fully recoverable — optional pay-only-for-qualified-cases model
Custom; bundled across litigation-support services
Primary audience
Personal injury & mass tort plaintiff firms wanting speed, scale, and medical-grade technology
Law firms, corporations, and insurance carriers
HIPAA / security
HIPAA-compliant under BAA, SOC 2 Type 2, bank-level encryption
SOC 2 Type 2, HIPAA

Competitor details sourced from public company materials (see sources). Figures a vendor does not publish are marked “not publicly disclosed.”

Proven Results

Real impact across major mass torts

How leading firms use LlamaLab to process thousands of cases faster.

Camp Lejeune
4 days
avg VA record retrieval
  • VA records delivered in 4 days on average vs. 90+ day industry standard
  • Cut one firm's budgeted processing time from 3 years to 6 months
View Interactive Story
PFAS Litigation
30,000+
cases processed
  • Processed 10,000 cases from no records to evidence packages in 3 weeks with an 87% qualification rate
  • Discovered exposure records linking clients to contaminated water sources
Depo-Provera
+20%
qualification rate increase
  • Raised proof-of-injury rate 20% by correcting teams' misinterpretation of records
  • Retrieved medical records going back 25+ years

LlamaLab vs U.S. Legal Support, answered

For plaintiff-side medical evidence, LlamaLab is more specialized — same-day retrieval, provider discovery, and clinical qualification. U.S. Legal Support is better for large organizations needing all-inclusive litigation support at maximum scale.

U.S. Legal Support is a large, all-inclusive litigation-support company where records are one of many services. LlamaLab is purpose-built for medical evidence with provider discovery and clinical case qualification for plaintiff and mass tort firms.

U.S. Legal Support prices custom and bundled. LlamaLab is retrieval-only with no platform fee, keeping the cost transparent and fully recoverable from settlement rather than absorbed as firm overhead.

For the medical-records part of a case, yes. LlamaLab does not offer court reporting, translations, or trial services, so firms relying on U.S. Legal Support for those would keep a separate vendor.

Large firms, corporations, or insurance carriers that want maximum-scale, all-inclusive litigation support across court reporting, translations, trial services, and records from a single national vendor.

Sources

See the difference on your own cases

Submit your first case free and compare LlamaLab's speed, provider discovery, and clinical qualification against what you use today.